A top pharmaceutical sponsor had 84 clinical trials worth of data they wanted to utilize to its full potential to research new therapies. However, due to regulations, patient data can only be used for what it was initially collected. On top of that, the data sets were all in different formats, making the mass anonymization of the data a lengthy and complicated process. The sponsor also wanted to measure the risk of re-identification. Typically, a project of this scope takes months to complete.
Complete the form to read about how the sponsor was able to anonymize 84 clinical trials’ worth of data and set all data sets to the same format in 30 minutes.